NCT06412913

Brief Summary

This study aims to retrospectively collect data from routine clinical practice in order to evaluate the safety profile of the MJ-FLEX elastic nail used in pediatric patients according to the manufacturer Instructions For Use (IFU) in the time frame from the time of surgery until the last follow-up visit available at the hospitals.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 30, 2024

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 14, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

July 19, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2025

Completed
Last Updated

August 28, 2025

Status Verified

August 1, 2025

Enrollment Period

8 months

First QC Date

April 30, 2024

Last Update Submit

August 27, 2025

Conditions

Keywords

nailelasticelastic nailingintramedullarypediatric

Outcome Measures

Primary Outcomes (4)

  • Percentage of procedures that have achieved bone union at the "bone consolidation assessment" visit

    The measurement of efficacy will be mande with the percentage of procedures that have achieved bone union

    After 5 month (approximately) from surgery

  • Percentage of procedures with at least one serious/not serious adverse event certainly related or possibly related to MJ-FLEX (ADEs/SADEs)

    This outcome will be used to measure safety

    from the date of surgery until the last follow-up, assessed up to 1 year

  • Percentage of procedures who experienced at least one MDDs that caused an effect on the patient

    This outcome will be used to measure safety

    from the date of surgery until the last follow-up, assessed up to 1 year

  • Post-treatment fracture-free survival

    This outcome will be used to measure safety

    up to 1 year

Study Arms (1)

Patients in pediatric age (> 18 month and < 18 years) at the time of surgery

The full analysis set includes all paediatric patients who that have been treated for diaphyseal fractures of long bones with the MJ-FLEX the will be systematically consecutive screened at the centers.

Device: MJ-Flex The New Metaizeau Nail

Interventions

Intramedullary implantation of the MJ-Flex elastic nail in long bones to provide bone fixation

Also known as: Elastic Nail
Patients in pediatric age (> 18 month and < 18 years) at the time of surgery

Eligibility Criteria

Age18 Months - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

The full analysis set includes all paediatric patients who that have been treated for diaphyseal fractures of long bones with the MJ-FLEX the will be systematically consecutive screened at the centers.

You may qualify if:

  • The patient has been adequately informed by providing the PIS. 1.1 The patient expressed his willingness to participate in the Study by signing and dating informed consent (valid only for UK patients according to local law).
  • Patients who had a regular indication for surgical intervention with MJ-Flex according to the manufacturer's IFU.
  • Patients in pediatric age (\> 18 month and \< 18 years) at the time of surgery.
  • Patients skeletally immature.
  • Patients who underwent surgery performed with MJ-Flex.
  • Patients with clinical data registered in her/him medical records sufficient to assess the safety and efficacy endpoint of the study: in particular, the patient has at least one follow-up at minimum 3 months from the surgery where is possible for the investigator to assess the consolidation of the treated bone.
  • The patient had surgery at least 1 year before enrollment.

You may not qualify if:

  • Patient who had/has a medical condition that is a contraindication according to the manufacturer's instruction for use leaflet.
  • Patient who had/has a concomitant not permitted device which cannot be safely removed.
  • Patient for whom there are other concurrent medical or other conditions that in the opinion of the participating investigator may prevent participation or otherwise render the patient ineligible for the study.
  • The patient had surgery less than 1 year before enrollment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheffield Children's NHS Foundation Trust

Sheffield, S10 2TH, United Kingdom

Location

MeSH Terms

Conditions

Fractures, Bone

Condition Hierarchy (Ancestors)

Wounds and Injuries

Study Officials

  • Sara Dorman, MD

    Sheffield Children's NHS Foundation Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 30, 2024

First Posted

May 14, 2024

Study Start

July 19, 2024

Primary Completion

March 28, 2025

Study Completion

March 28, 2025

Last Updated

August 28, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations